| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Soligenix, Inc. (SNGX) has 8 insiders with recent SEC Form 4 filings, including 11 buys and 3 sells. SNGX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 200.0K | $58.6K | - | |
| Other | 100.0K | $29.3K | - | |
| CFO | 100.0K | $29.3K | - | |
| ? | 17.6K | $5.2K | - | |
| ? | 17.6K | $5.2K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 19, 2019 | Zeldis Jerome B45 | Director | Buy | 2,000 | $0.93 | $1,850.00 | +9.6% | |
| Sep 23, 2019 | Parks Diane L. | Director | Buy | 14,940 | $0.93 | $13,870.30 | New | |
| Sep 19, 2019 | Zeldis Jerome B45 | Director | Buy | 4,000 | $0.94 | $3,740.00 | +23.6% | |
| Apr 22, 2019 | Schaber Christopher J | Chairman, CEO And President | Buy | 5,000 | $0.72 | $3,577.00 | +13.4% | |
| Apr 22, 2019 | Zeldis Jerome B45 | Director | Buy | 10,000 | $0.73 | $7,274.00 | +144.6% | |
| Oct 18, 2018 | Schaber Christopher J | Chairman, CEO And President | Buy | 8,700 | $1.17 | $10,177.26 | +30.4% | |
| Oct 17, 2018 | Pearson Mark E. | Director | Buy | 170,000 | $1.16 | $197,200.00 | +7.3% | |
| Aug 22, 2018 | Schaber Christopher J | Chairman, CEO And President | Buy | 3,530 | $1.42 | $5,011.89 | +14.1% | |
| Nov 29, 2017 | Essetifin Spa | Former 10% Owner | Sell | 293,510 | $2.12 | $622,241.20 | -100% | |
| Nov 29, 2017 | Essetifin Spa | Former 10% Owner | Buy | 293,510 | $2.12 | $622,241.20 | +53.5% |